{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_irinotecan",
          "name": "Irinotecan"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_carboplatin",
          "name": "Carboplatin"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cisplatin",
          "name": "Cisplatin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_gemcitabine",
          "name": "Gemcitabine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_procarbazine",
          "name": "Procarbazine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_target1",
          "type": "Target",
          "label": "Topoisomerase II",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "DNA Alkylator",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target3",
          "type": "Target",
          "label": "Antimetabolite",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target4",
          "type": "Target",
          "label": "Microtubule Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target5",
          "type": "Target",
          "label": "Vascular Endothelial Growth Factor (VEGF)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Cell Cycle Regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Tumour Syndromes of the CNS",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_doxorubicin",
          "type": "Target",
          "label": "OffTarget1_Doxorubicin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_doxorubicin",
          "type": "Pathway",
          "label": "RiskPathway_Doxorubicin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_doxorubicin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Doxorubicin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_temozolomide",
          "type": "Target",
          "label": "OffTarget1_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_temozolomide",
          "type": "Pathway",
          "label": "RiskPathway_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_temozolomide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_vincristine",
          "type": "Target",
          "label": "OffTarget1_Vincristine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_vincristine",
          "type": "Pathway",
          "label": "RiskPathway_Vincristine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_vincristine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Vincristine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTarget1_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathway_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotype_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclophosphamide",
          "type": "Target",
          "label": "OffTarget1_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclophosphamide",
          "type": "Pathway",
          "label": "RiskPathway_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclophosphamide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_irinotecan",
          "type": "Target",
          "label": "OffTarget1_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_irinotecan",
          "type": "Pathway",
          "label": "RiskPathway_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_irinotecan",
          "type": "Phenotype",
          "label": "AdversePhenotype_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etoposide",
          "type": "Target",
          "label": "OffTarget1_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etoposide",
          "type": "Pathway",
          "label": "RiskPathway_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etoposide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_carboplatin",
          "type": "Target",
          "label": "OffTarget1_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_carboplatin",
          "type": "Pathway",
          "label": "RiskPathway_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_carboplatin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cisplatin",
          "type": "Target",
          "label": "OffTarget1_Cisplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cisplatin",
          "type": "Pathway",
          "label": "RiskPathway_Cisplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cisplatin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Cisplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_bevacizumab",
          "type": "Target",
          "label": "OffTarget1_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bevacizumab",
          "type": "Pathway",
          "label": "RiskPathway_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bevacizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_gemcitabine",
          "type": "Target",
          "label": "OffTarget1_Gemcitabine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_gemcitabine",
          "type": "Pathway",
          "label": "RiskPathway_Gemcitabine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_gemcitabine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Gemcitabine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_procarbazine",
          "type": "Target",
          "label": "OffTarget1_Procarbazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_procarbazine",
          "type": "Pathway",
          "label": "RiskPathway_Procarbazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_procarbazine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Procarbazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Temozolomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Vincristine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Irinotecan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_irinotecan",
          "type": "Drug",
          "label": "Irinotecan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Etoposide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Carboplatin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_carboplatin",
          "type": "Drug",
          "label": "Carboplatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Cisplatin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cisplatin",
          "type": "Drug",
          "label": "Cisplatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bevacizumab",
          "type": "Drug",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Gemcitabine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_gemcitabine",
          "type": "Drug",
          "label": "Gemcitabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Procarbazine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_procarbazine",
          "type": "Drug",
          "label": "Procarbazine",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_doxorubicin",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知靶点，有效性支持"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "DNA 甲基化机制连接"
        },
        {
          "source": "drug_vincristine",
          "target": "n_target4",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "微管靶向药物的作用"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_target3",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抗代谢药的作用机制"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与DNA损伤机制相关"
        },
        {
          "source": "drug_irinotecan",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与topoisomerase II的关系"
        },
        {
          "source": "drug_etoposide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知机制关联"
        },
        {
          "source": "drug_carboplatin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "DNA交联机制"
        },
        {
          "source": "drug_cisplatin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "DNA交联机制"
        },
        {
          "source": "drug_bevacizumab",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "VEGF靶向治疗"
        },
        {
          "source": "n_target1",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路反应的一部分"
        },
        {
          "source": "n_target2",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Apoptosis通路关联"
        },
        {
          "source": "n_target3",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "抗代谢药物的通路有效性"
        },
        {
          "source": "n_target4",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "微管靶向作用途径"
        },
        {
          "source": "n_pathway1",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路与疾病关联"
        },
        {
          "source": "n_pathway2",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "重要的病理通路"
        },
        {
          "source": "drug_doxorubicin",
          "target": "H1",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_temozolomide",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_vincristine",
          "target": "H3",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_methotrexate",
          "target": "H4",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_irinotecan",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_etoposide",
          "target": "H7",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_carboplatin",
          "target": "H8",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_cisplatin",
          "target": "H9",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_bevacizumab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_gemcitabine",
          "target": "H11",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_procarbazine",
          "target": "H12",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_doxorubicin",
          "target": "n_ot_doxorubicin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_doxorubicin",
          "target": "n_rp_doxorubicin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_doxorubicin",
          "target": "n_adv_doxorubicin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_doxorubicin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_ot_temozolomide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_temozolomide",
          "target": "n_rp_temozolomide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_temozolomide",
          "target": "n_adv_temozolomide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_temozolomide",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_vincristine",
          "target": "n_ot_vincristine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_vincristine",
          "target": "n_rp_vincristine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_vincristine",
          "target": "n_adv_vincristine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_vincristine",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_ot_cyclophosphamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_cyclophosphamide",
          "target": "n_rp_cyclophosphamide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_cyclophosphamide",
          "target": "n_adv_cyclophosphamide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_cyclophosphamide",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_irinotecan",
          "target": "n_ot_irinotecan",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_irinotecan",
          "target": "n_rp_irinotecan",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_irinotecan",
          "target": "n_adv_irinotecan",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_irinotecan",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_etoposide",
          "target": "n_ot_etoposide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_etoposide",
          "target": "n_rp_etoposide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_etoposide",
          "target": "n_adv_etoposide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_etoposide",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_carboplatin",
          "target": "n_ot_carboplatin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_carboplatin",
          "target": "n_rp_carboplatin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_carboplatin",
          "target": "n_adv_carboplatin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_carboplatin",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_cisplatin",
          "target": "n_ot_cisplatin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_cisplatin",
          "target": "n_rp_cisplatin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_cisplatin",
          "target": "n_adv_cisplatin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_cisplatin",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_bevacizumab",
          "target": "n_ot_bevacizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_bevacizumab",
          "target": "n_rp_bevacizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_bevacizumab",
          "target": "n_adv_bevacizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_bevacizumab",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_gemcitabine",
          "target": "n_ot_gemcitabine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_gemcitabine",
          "target": "n_rp_gemcitabine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_gemcitabine",
          "target": "n_adv_gemcitabine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_gemcitabine",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        },
        {
          "source": "drug_procarbazine",
          "target": "n_ot_procarbazine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响关键靶器官"
        },
        {
          "source": "n_ot_procarbazine",
          "target": "n_rp_procarbazine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在安全性风险通路"
        },
        {
          "source": "n_rp_procarbazine",
          "target": "n_adv_procarbazine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良表型"
        },
        {
          "source": "n_adv_procarbazine",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消使用获益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H4_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H5_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_irinotecan",
          "name": "Irinotecan"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H6_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H7_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_carboplatin",
          "name": "Carboplatin"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H8_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_cisplatin",
          "name": "Cisplatin"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H9_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H10_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_gemcitabine",
          "name": "Gemcitabine"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H11_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_procarbazine",
          "name": "Procarbazine"
        },
        "score": 0.0,
        "graph_snapshot_ref": "GE_H12_round2",
        "key_assumptions": [
          "存在严重不良表型影响使用获益"
        ],
        "caveats": [
          "潜在严重不良表型的风险反向影响了整体效益"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "不良表型风险影响所有候选药的使用可行性",
          "reason": "所有候选药物均存在潜在的严重不良表型"
        }
      ],
      "remaining_gaps": [
        "尚未明确不良反应的可逆性及其与药物效益比例关系"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [],
          "impact_summary": "无种子生成，需关注新机制下的潜在不良反应"
        }
      ],
      "lessons": [
        "针对每个候选药物的潜在不良反应需明确可逆性与效益的比例"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "聚焦不良表型潜在风险的可逆性研究"
      },
      {
        "role": "Skeptic",
        "patch": "明确不良反应的临床表现及其严重性"
      },
      {
        "role": "Explorer",
        "patch": "关注新候选药的独特机制以及不良反应相关性"
      }
    ],
    "heuristics": [
      {
        "when": "肿瘤相关药物",
        "then": "严格评估可能存在的严重不良表型"
      },
      {
        "when": "评估药物效效比",
        "then": "关注可逆性与收益权衡"
      }
    ]
  }
}